These studies suggest that local tumor cell-produced HGFL plays a key role in mammary tumorigenesis (acting on tumor cells and immune cells in the TME) while physiologic sources of HGFL (primarily hepatocyte-derived) are permissive for tumor growth and may sustain the tumor prior to HGFL upregulation in the tumor proper. This evidence concerns the gene MST1 and neoplasm.